Publications by authors named "Catherine Nutt"

Claim this Profile
M
Musculoskeletal Injuries and Illness in Professional British Tennis Players: An Injury Surveillance Study.
Catherine Nutt, Steve McCaig, Stephen-Mark Cooper

Int J Sports Phys Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REFERENCE VALUES FOR GLENOHUMERAL JOINT ROTATIONAL RANGE OF MOTION IN ELITE TENNIS PLAYERS.
Catherine Nutt, Milena Mirkovic, Robert Hill, Craig Ranson, Stephen-Mark Cooper

Int J Sports Phys Ther· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computationally simple analysis of matched, outcome-based studies of ordinal disease states.
Rebecca A Betensky, Jackie Szymonifka, Eudocia Q Lee, Catherine L Nutt, Tracy T Batchelor

Stat Med· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supervised Bayesian latent class models for high-dimensional data.
Stacia M Desantis, E Andrés Houseman, Brent A Coull, Catherine L Nutt, Rebecca A Betensky

Stat Med· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A sensitive and specific diagnostic panel to distinguish diffuse astrocytoma from astrocytosis: chromosome 7 gain with mutant isocitrate dehydrogenase 1 and p53.
Sandra Camelo-Piragua, Michael Jansen, Aniruddha Ganguly, James ChulMin Kim, Arjola K Cosper, Catherine L Nutt

J Neuropathol Exp Neurol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased expression of angiogenic genes in the brains of mouse meg3-null embryos.
Francesca E Gordon, Catherine L Nutt, Pornsuk Cheunsuchon, Yuki Nakayama, Katelyn A Provencher

Endocrinology· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutant IDH1-specific immunohistochemistry distinguishes diffuse astrocytoma from astrocytosis.
Sandra Camelo-Piragua, Michael Jansen, Aniruddha Ganguly, J Chulmin Kim, David N Louis, Catherine L Nutt

Acta Neuropathol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multigene predictor of outcome in glioblastoma.
Howard Colman, Li Zhang, Erik P Sulman, J Matthew McDonald, Nasrin Latif Shooshtari, Catherine L Nutt

Neuro Oncol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.
Stephen Yip, Jiangyong Miao, Daniel P Cahill, A John Iafrate, Ken Aldape, Catherine L Nutt

Clin Cancer Res· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamide.
Xue Qing Lun, Ji-Hyun Jang, Nan Tang, Helen Deng, Renee Head, Catherine L Nutt

Clin Cancer Res· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness.
Núria de la Iglesia, Genevieve Konopka, Kah-Leong Lim, Catherine L Nutt, Jacqueline F Bromberg

J Neurosci· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2.
Audrey Rousseau, Catherine L Nutt, Rebecca A Betensky, A John Iafrate, Moonjoo Han

J Neuropathol Exp Neurol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival.
Masahiro Mizoguchi, Rebecca A Betensky, Tracy T Batchelor, Derek C Bernay, David N Louis, Catherine L Nutt

J Neuropathol Exp Neurol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histology-based expression profiling yields novel prognostic markers in human glioblastoma.
Shumin Dong, Catherine L Nutt, Rebecca A Betensky, Anat O Stemmer-Rachamimov, Nicholas C Denko

J Neuropathol Exp Neurol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular genetics of oligodendrogliomas: a model for improved clinical management in the field of neurooncology.
Catherine L Nutt

Neurosurg Focus· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autocrine platelet-derived growth factor-dependent gene expression in glioblastoma cells is mediated largely by activation of the transcription factor sterol regulatory element binding protein and is associated with altered genotype and patient survival in human brain tumors.
Deqin Ma, Catherine L Nutt, Piam Shanehsaz, Xuejun Peng, David N Louis

Cancer Res· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations of the PIK3CA gene are rare in human glioblastoma.
Wolf Mueller, Masahiro Mizoguchi, Erica Silen, Katrina D'Amore, Catherine L Nutt

Acta Neuropathol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statistical considerations for immunohistochemistry panel development after gene expression profiling of human cancers.
Rebecca A Betensky, Catherine L Nutt, Tracy T Batchelor, David N Louis

J Mol Diagn· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas.
Catherine L Nutt, Rebecca A Betensky, Melissa A Brower, Tracy T Batchelor, David N Louis

Clin Cancer Res· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic alterations of phosphoinositide 3-kinase subunit genes in human glioblastomas.
Masahiro Mizoguchi, Catherine L Nutt, Gayatry Mohapatra, David N Louis

Brain Pathol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas.
Keith L Ligon, John A Alberta, Alvin T Kho, Jennifer Weiss, Mary R Kwaan, Catherine L Nutt

J Neuropathol Exp Neurol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutation analysis of CBL-C and SPRED3 on 19q in human glioblastoma.
Masahiro Mizoguchi, Catherine L Nutt, David N Louis

Neurogenetics· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.
Catherine L Nutt, D R Mani, Rebecca A Betensky, Pablo Tamayo, J Gregory Cairncross

Cancer Res· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection pressures of TP53 mutation and microenvironmental location influence epidermal growth factor receptor gene amplification in human glioblastomas.
Yoshifumi Okada, Edward E Hurwitz, John M Esposito, Melissa A Brower, Catherine L Nutt

Cancer Res· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis